Biopsy Devices Market is estimated to be US$ 3.69 billion by 2030 with a CAGR of 6.1% during the forecast period

 



Biopsy Devices Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 3.69 billion by 2030 and is anticipated to register a CAGR of 6.1%. The biopsy is used to perform surgical removal of tissue from an organ to determine the extent of disease, generally inflammatory and cancerous conditions. They perform by radiologists, interventional cardiologists, and surgeons. Each biopsy device is used according to the types of the organ under consideration. Conventional biopsy devices are complemented with advanced imaging technologies, like a stereotactic-guided biopsy, MRI-guided biopsy, CT scans, ultrasound-guided biopsy, and others to perform a biopsy with minimal invasiveness.  Equipment like forceps, aspiration needles and localization wires are commonly used in biopsy devices. These devices are used in the needle-based, core, and vacuum-assisted biopsies of body parts, including the lungs, breast, liver, and kidney. They have various applications in healthcare such as diagnostic centers, medical clinics, and hospitals.

The report " Global Biopsy Devices Market, By Device Type (Breast biopsy devices, Gastrointestinal (GI) biopsy devices, Soft tissue biopsy devices, Bronchial biopsy devices, Gynecological biopsy devices, Robotic biopsy devices, and Other devices), By Imaging Technology (CT scan, Stereotactic-guided biopsy, Ultrasound-guided biopsy, MRI-guided biopsy, and Others), By Application (Breast biopsy, Gastrointestinal (GI) biopsy, Prostate, Liver, Lung, Kidney, Gynecological, and Others), By End-User (Diagnostics and Hospitals), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”

Key Highlights:

  • On 16 March 2021, IZI Medical Products, LLC leading manufacturer of medical devices for radiology and oncology procedures, launched fully automated Quick-Core Auto Biopsy System for soft tissue biopsy. The Quick-Core Auto is a fully automatic biopsy device and lightweight, that builds upon the legacy of IZI's Quick-Core semi-automatic biopsy system, and offers the same reliability, precision, and quality. 
  • Hologic announced enhancement in Brevera with CorLumina Imaging Technology in August 2020. Which integrates vacuum-assisted tissue acquisition, real-time imaging verification, and advanced post-biopsy handling, the innovation will fuel the customer base of the firm.
  • On 24 February 2021, Twist Bioscience Launched Industry-Leading NGS Methylation Detection System for Liquid Biopsy Cancer Analysis and Epigenetic Studies. Company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and a robust, end-to-end sample preparation and target enrichment solution for identifying methylated regions in the human genome.

Analyst View:

The increasing instance of chronic medical ailments, mainly breast cancer, is the key factor driving the growth of the market. In addition, increasing consumer awareness regarding the availability of screening procedures and diagnostics for chronic disease is rising the demand for integral technologies such as stereotactic-guided biopsies. Growing preference for minimally invasive (MI) biopsy procedures among patients across the globe is increasing the growth of the biopsy device market, For instance, the MI breast biopsy technique (MIBT) eliminates the need for surgery of cancer diagnosis while preserving the healthy tissue from damage caused by radiation. Furthermore, technological advancements include the development of vacuum-assisted guns and smart biopsy system that aid in distinguishing healthy cells from tumorous ones which also supports the growth of the market. The rapidly growing geriatric population, extensive research, and development activities increasing healthcare expenditure are driving the market in the coming years.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230

 

Key Market Insights from the report:

Global Biopsy Devices Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 3.69 billion by 2030 and is anticipated to register a CAGR of 6.1%. The Global Biopsy Devices Market is segmented by Device Type, Application, Imaging Technology, End-user, and Region.

·         By Device type, Global Biopsy Devices Market is segmented into Breast biopsy devices, Gastrointestinal (GI) biopsy devices, Soft tissue biopsy devices, Bronchial biopsy devices, Gynecological biopsy devices, Robotic biopsy devices, and other devices.

·         By Application, Global Biopsy Devices Market is segmented into Breast biopsy, Gastrointestinal (GI) biopsy, Prostate, Liver, Lung, Kidney, Gynecological, and Others.

·         By imaging technology, Global Biopsy Devices Market is segmented into CT scan, Stereotactic-guided biopsy, Ultrasound-guided biopsy, MRI-guided biopsy, and others.

·         By End user, Global Biopsy Devices Market is segmented into Diagnostics and Hospitals.

·         By Region, Global Biopsy Devices Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Competitive Landscape:

·         The key operators of the Global Biopsy Devices Market are Bard Inc., Leica Biosystems, Dickinson and Company, Ethicon EndoSurgery Inc., Fujifilm Medical Systems, Veran Medical Technologies, Boston Scientific Corporation, MDxHealth, Medtronic, Argon Medical Devices Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Patient Portal Market is estimated to be US$ 7862.01 billion by 2030 with a CAGR of 11.50% during the forecast period

Image
  Patient Portal Market  accounted for US$ 2643.21 million in 2020 and is estimated to be US$ 7862.01 million by 2030 and is anticipated to register a CAGR of 11.50%. The patients can share and view their health information and communicate remotely. These characteristics enables patients to look into various data points, such as diagnostic test results, medical history, and prescription information. Patient portal is one of the many tools that allow the healthcare payers and providers to arrive at outcomes, which are patient-centric. Rapid technological advancements in the digital space are rising the engagement level of patients in the entire healthcare ecosystem. Data points collected on a per-patient basis through patient portal can be used for performing pin-point diagnosis, designing better clinical trials, and helping in the elimination of administration of redundant therapies and drugs to individual patients. The report   "   Global Patient Portal Market, By P...
Read more

Knee Replacement Market is estimated to be 14.2 billion by 2029 with a CAGR of 4.3% during the forecasted period.

Image
  knee replacement market  accounted for 9.7 billion in 2020 and is estimated to be US$ 14.2 billion by 2029 and is anticipated to register a CAGR of 4.3%. The report " Global Knee Replacement Market, By Product ( Total Knee Replacement, Partial Knee Replacement, Kneecap Replacement, and Complex (or revision) Knee Replacement),  By End Users ( Hospitals, Orthopedic Centers, and Other ),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In March 2018, Smith and Nephew announced commercial release of bi-cruciate retaining Journey II XR total knee arthroplasty across the U.S. and Japan. The product launch was aimed at capturing large customer base with innovative product offering. In October 2018, Zimmer Biomet Holdings announced to collaborate with Apple to facilitate patient and surgeon connection during the knee and hip replacement procedures. Th...
Read more

Nuclear Medicine Market is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period

Image
  The Nuclear Medicine Market accounted for US$ 4.26 billion and is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period. Nuclear medicine may be a medicine involving the appliance of radioactive substances within the diagnosis and treatment of disease. Medicine imaging, during a sense, is "radiology done inside out" or "endoradiology" because it records radiation emitting from within the body instead of radiation that's generated by external sources like X-rays. Additionally, medicine scans differ from radiology, because the emphasis isn't on imaging anatomy, but on the function. For such reason, it's called a physiological imaging modality. Single photon emission computerized tomography (SPECT) and positron emission tomography (PET) scans are the 2 commonest imaging modalities in medicine.   The report "  Global Nuclear Medicine Market, By Diagnostics (Single Photon Emission, Computed Tomography (SPECT), an...
Read more